Poseida Therapeutics, Inc. Tech Stack

Poseida Therapeutics, Inc. uses 8 technology products and services including Power BI, Akamai, Typekit, and more. Explore Poseida Therapeutics, Inc.'s tech stack below.

  • Power BI
    Business Intelligence
  • Akamai
    Content Delivery Network
  • Typekit
    Font Scripts
  • Java
    Programming Languages
  • X-XSS-Protection
    Security
  • Adobe Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • Adobe Creative Suite
    Visualisation Software

Media & News

Poseida Therapeutics, Inc.'s Email Address Formats

Poseida Therapeutics, Inc. uses at least 4 format(s):
Poseida Therapeutics, Inc. Email FormatsExamplePercentage
flast@poseida.comJDoe@poseida.com
33%
fmiddlelast@poseida.comJMichaelDoe@poseida.com
34%
lfirst@poseida.comDJohn@poseida.com
16%
last@poseida.comDoe@poseida.com
17%

Frequently Asked Questions

Where is Poseida Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc.'s main headquarters is located at 9390 Towne Centre Dr 200 San Diego, California 92121 US. The company has employees across 3 continents, including North AmericaSouth AmericaEurope.

What is Poseida Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Poseida Therapeutics, Inc.'s main corporate office by phone at +1-858-779-3100. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Poseida Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc. is a publicly traded company; the company's stock symbol is PSTX.

What is Poseida Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc.'s official website is poseida.com and has social profiles on LinkedIn.

How much revenue does Poseida Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of March 2024, Poseida Therapeutics, Inc.'s annual revenue reached $75M.

What is Poseida Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Poseida Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2024, Poseida Therapeutics, Inc. has approximately 324 employees across 3 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Scientific Officer, Cell Therapy: D. J. S.Chief People & Administration Officer: K. M.Chief Financial Officer: J. M.. Explore Poseida Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Poseida Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Poseida Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc.'s tech stack includes Power BIAkamaiTypekitJavaX-XSS-ProtectionAdobe Tag ManagerBootstrapAdobe Creative Suite.

What is Poseida Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc.'s email format typically follows the pattern of flast@poseida.com. Find more Poseida Therapeutics, Inc. email formats with LeadIQ.

How much funding has Poseida Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2024, Poseida Therapeutics, Inc. has raised $50M in funding. The last funding round occurred on Aug 07, 2023.

When was Poseida Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Poseida Therapeutics, Inc. was founded in 2014.
Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies as well as in-house cell therapy manufacturing. The Company has formed a global strategic collaboration with Roche to unlock the promise of cell therapies for patients with hematological malignancies. Learn more at www.poseida.com.

Section iconCompany Overview

Headquarters
9390 Towne Centre Dr 200 San Diego, California 92121 US
Phone number
+1-858-779-3100
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PSTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconFunding & Financials

  • $50M

    Poseida Therapeutics, Inc. has raised a total of $50M of funding over 9 rounds. Their latest funding round was raised on Aug 07, 2023.

  • $50M$100M

    Poseida Therapeutics, Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M

    Poseida Therapeutics, Inc. has raised a total of $50M of funding over 9 rounds. Their latest funding round was raised on Aug 07, 2023.

  • $50M$100M

    Poseida Therapeutics, Inc.'s revenue is in the range of $50M$100M

© LeadIQ, Inc. All rights reserved.